Douglas Calder

Douglas Calder

Director/Board Member at ZEVRA THERAPEUTICS, INC.

Net worth: 18 748 $ as of 2026-09-29

59 year
Health Technology
Technology Services
Finance

Profile

Mr. Douglas W.
Calder
is an Independent Director at Lunai Bioworks, Inc., an Independent Director at Zevra Therapeutics, Inc. and a Member at Society For Natural Immunity.
He is on the Board of Directors at Lunai Bioworks, Inc., Zevra Therapeutics, Inc., Nextgennk and BioFlorida, Inc. Mr. Calder was previously employed as a President & Director by Vycellix, Inc., a Director-Investor Relations & Public Relations by Accentia Biopharmaceuticals, Inc., a VP-Strategic Planning & Capital Markets by BioVest International, Inc., a Portfolio Manager by Dean Witter Reynolds, Inc., a Portfolio Manager by Gruntal & Co. LLC, an Executive Vice President by Pulse Evolution Corp., and a President by VyGen-Bio, Inc. He received his undergraduate degree from Florida State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-10-12 12,754 ( 0.25% ) 18 748 $ 2026-09-29
2026-06-03 0 ( -.--% ) - $ 2026-09-29

Douglas Calder active positions

CompaniesPositionStart
ZEVRA THERAPEUTICS, INC. Director/Board Member 2023-04-24
Nextgennk
Director/Board Member 2019-05-31
Director/Board Member 2018-12-31

Former positions of Douglas Calder

CompaniesPositionEnd
LUNAI BIOWORKS INC. Director/Board Member 2026-10-21
Investor Relations Contact 2013-07-15
ACCENTIA BIOPHARMACEUTICALS INC Investor Relations Contact 2013-03-03
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Douglas Calder's experience

Education of Douglas Calder

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

45

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Finance

Government

Consumer Services

Commercial Services

Health Technology

Nextgennk

Health Technology

  1. Stock Market
  2. Insiders
  3. Douglas Calder